4/A//SEC Filing
LaMond Stephen J 4/A
Accession 0000950170-23-050434
CIK 0001834645other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 4:05 PM ET
Size
6.5 KB
Accession
0000950170-23-050434
Insider Transaction Report
Form 4/AAmended
Peak Bio, Inc.PKBO
LaMond Stephen J
DirectorSee Remarks
Transactions
- Purchase
Common Stock
2023-09-18+2,500→ 14,250 total - Purchase
Common Stock
2023-09-15+11,750→ 11,750 total
Footnotes (2)
- [F1]Dr. LaMond previously reported purchases of 26,000 shares of the Company's Common Stock on September 15, 2023 in error. Instead, on September 15, 2023, Dr. Stephen LaMond purchased a total of 11,750 shares of the Company's Common Stock at prices ranging from $0.27 per share to $0.43 per share.
- [F2]On September 18, 2023, Dr. Stephen LaMond purchased a total of 2,500 shares of the Company's Common Stock at prices ranging from $0.23 per share to $0.29 per share.
Documents
Issuer
Peak Bio, Inc.
CIK 0001834645
Entity typeother
Related Parties
1- filerCIK 0001951073
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 4:05 PM ET
- Size
- 6.5 KB